Literature DB >> 2026480

Phase II trial of echinomycin in advanced colorectal cancer. A Southwest Oncology Group study.

T D Brown1, P J Goodman, T R Fleming, S A Taylor, J S Macdonald.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 2026480     DOI： 10.1007/bf00194561

Source DB:  PubMed          Journal:  Invest New Drugs        ISSN： 0167-6997            Impact factor:   3.850


× No keyword cloud information.
  5 in total

1.  Experimental antitumor activity and toxicity of a new chemotherapeutic agent, BBM 928A.

Authors:  W C Rose; J E Schurig; J B Huftalen; W T Bradner
Journal:  Cancer Res       Date:  1983-04       Impact factor: 12.701

2.  One-sample multiple testing procedure for phase II clinical trials.

Authors:  T R Fleming
Journal:  Biometrics       Date:  1982-03       Impact factor: 2.571

3.  Reporting results of cancer treatment.

Authors:  A B Miller; B Hoogstraten; M Staquet; A Winkler
Journal:  Cancer       Date:  1981-01-01       Impact factor: 6.860

4.  Bifunctional intercalation of antitumor antibiotics BBM-928A and echinomycin with deoxyribonucleic acid. Effects of intercalation on deoxyribonucleic acid degradative activity of bleomycin and phleomycin.

Authors:  C H Huang; A W Prestayko; S T Crooke
Journal:  Biochemistry       Date:  1982-07-20       Impact factor: 3.162

5.  Phase I study of echinomycin.

Authors:  R Pazdur; C D Haas; L H Baker; C G Leichman; D Decker
Journal:  Cancer Treat Rep       Date:  1987-12
  5 in total
  3 in total

1.  Phase II trial of echinomycin in patients with advanced or recurrent colorectal cancer.

Authors:  S Wadler; L Tenteromano; L Cazenave; J A Sparano; E S Greenwald; A Rozenblit; R Kaleya; P H Wiernik
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

2.  Characterization of Streptomyces sp. LS462 with high productivity of echinomycin, a potent antituberculosis and synergistic antifungal antibiotic.

Authors:  Caixia Chen; Xiangyin Chen; Biao Ren; Hui Guo; Wael M Abdel-Mageed; Xueting Liu; Fuhang Song; Lixin Zhang
Journal:  J Ind Microbiol Biotechnol       Date:  2021-12-23       Impact factor: 4.258

3.  Quinomycin A targets Notch signaling pathway in pancreatic cancer stem cells.

Authors:  Sivapriya Ponnurangam; Prasad R Dandawate; Animesh Dhar; Ossama W Tawfik; Rajashri R Parab; Prabhu Dutt Mishra; Prafull Ranadive; Rajiv Sharma; Girish Mahajan; Shahid Umar; Scott J Weir; Aravind Sugumar; Roy A Jensen; Subhash B Padhye; Arun Balakrishnan; Shrikant Anant; Dharmalingam Subramaniam
Journal:  Oncotarget       Date:  2016-01-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.